Search for: "Amarin Pharma, Inc. v. International Trade Commission" Results 1 - 4 of 4
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 May 2019, 9:02 pm by Patent Docs
But the Commission's powers are circumscribed in other ways, as illustrated by the Federal Circuit's decision last week in Amarin Pharma, Inc. v. [read post]
30 Aug 2017, 6:59 pm by FDABlog HPM
  Now, Amarin aligns itself closely to the FDC Act and years of related FDA interpretations as the company seeks to break even more new ground by turning its sights on a new target: synthetic omega-3 oil manufacturers and dietary supplement distributors; and in a new forum: the United States International Trade Commission (“ITC”). [read post]